Class II · Moderate risk
Tirosint - Sol
Subpotent Drug
Is Levothyroxine recalled?
Yes — there is an active recall. 62 ongoing FDA recalls mention Levothyroxine (186 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Levothyroxine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Levothyroxine recalls on record
none so far in 2026; 186 on record, newest first
Class II · Moderate risk
Tirosint - Sol
Subpotent Drug
Class II · Moderate risk
Tirosint - Sol
Subpotent Drug
Class II · Moderate risk
Tirosint - Sol
Subpotent Drug
Class II · Moderate risk
Tirosint - Sol
Subpotent Drug
Class II · Moderate risk
Levothyroxine 25mcg in Ns 1.25ml Syringe
Lack of sterility assurance
Class II · Moderate risk
Levothyroxine Sodium Tablets
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II · Moderate risk
TIROSINT (levothyroxine sodium)
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II · Moderate risk
Synthroid (levothyroxine sodium tablets, USP)
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II · Moderate risk
Nature-Throid 1 GR
CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.
Class II · Moderate risk
Nature-Throid
CGMP Deviations
Class II · Moderate risk
Nature-Throid
CGMP Deviations
Class II · Moderate risk
Nature-Throid
CGMP Deviations
Class II · Moderate risk
Nature-Throid
CGMP Deviations
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
WP Thyroid
Subpotent Drug: FDA analysis found product to be subpotent
Class II · Moderate risk
WP Thyroid
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class II · Moderate risk
Nature-Throid
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class II · Moderate risk
Nature-Throid
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class II · Moderate risk
Nature-Throid
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class II · Moderate risk
Nature-Throid
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.